Searchable abstracts of presentations at key conferences in endocrinology

ea0020p60 | Thyroid | ECE2009

The value of TSH-assisted 18F-FDG PET in initial stage M0 thyroid carcinoma with suspicion of residual or recurrent disease

Taieb David , Ghander Cecile , Sebag Frederic , Tessonnier Laurent , Palazzo F Fausto , De Micco Catherine , Henry Jean-Francois , Mundler Olivier

Purpose: Persistence of well-differentiated thyroid carcinoma most commonly involves cervical lymph nodes. The purposes of the study were to evaluate the ability of FDG-PET/CT imaging to localize residual disease in initial stage M0 thyroid carcinoma thyroid cancer patients and to compare FDG-PET/CT to neck US.Methods: FDG-PET/CT and neck US results of 93 patients were retrospectively analysed. All FDG-PET/CT were performed during thyrotropin stimulation...

ea0020p108 | Thyroid | ECE2009

Quality of life changes, clinical outcomes and radiation protection issues in thyroid cancer patients undergoing radioiodine remnant ablation with recombinant human thyrotropin: a randomized controlled study

David Taieb , Frederic Sebag , Maria Cherenko , Karine Baumstarck-Barrau , Farman-Ara Bardia , De Micco Catherine , Henry Jean Francois , Mundler Olivier

Background: Recombinant human TSH (rhTSH) has become the modality of choice for radioiodine remnant ablation of residual thyroid cancer tissue in low-risk patients.Methods: The FACIT-F was administered from the early postoperative period to 9 months. Socio-demographic parameters, anxiety and depression scales were also evaluated. At 24 h, 48 h and d6 post-therapy, dose rate were measured. Using a simplified model, radiation exposure to public was estimat...

ea0020p189 | Endocrine tumours and neoplasia | ECE2009

Tumor/liver standardized uptake values ratio <1.8 on FDG-PET has a high negative predicitive value to rule-out malignancy in patients with incidentally identified non-secreting adrenal tumours

Taieb David , Tessonnier Laurent , Sebag Frederic , Morange Isabelle , De Micco Catherine , Conte-Devolx Bernard , Henry Jean-Francois , Mundler Olivier

Purpose: The widespread use of high resolution cross-sectional imaging such as computer tomography (CT) and magnetic resonance imaging (MRI) for the investigation of the abdomen is associated with an increasing detection of incidental adrenal masses. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) has proved to be an efficient tool in the diagnosis and follow-up of malignancies. We evaluated the ability of FDG-PET to distinguish benign from malignant adrenal mass...